John P. Redrobe

Lundbeck A/S, Denmark

John P. Redrobe completed his M.S. degree in pharmacology/toxicology in 1995 under the supervision of Professor Brian Leonard at the National University of Ireland, Ireland, and Professor Philip Chambers at Trinity College, University of Dublin, Ireland. He then went on to complete his Ph.D. studies in 1998 at the University of Nantes, France, under the supervision of Professor Michel Bourin. Since then, his work concentrated on the mechanisms of antidepressant action in animal models of depression and anxiety. Dr. Redrobe then went on to complete his postdoctoral studies at McGill University, Canada, under the supervision of Dr. Rémi Quirion. Here his work concentrated on the potential role played by the neuropeptides NPY and nociceptin in depression, anxiety, and learning/memory processing, and the possible interactions with monoamine neurotransmission. Since completing his postdoctoral studies in 2001, Dr. Redrobe has held positions at Neuro3d (Strasbourg, France) where he served as Head of the Departments of Behavioural Pharmacology and Neurosearch A/S (Ballerup, Denmark) where he was In Vivo Specialist/Scientific Officer for in-house/external depression/anxiety/cognition programs. He currently holds the position of a Senior Research Scientist at H. Lundbeck A/S (Valby, Denmark). During his career, Dr. Redrobe has held teaching and supervision responsibilities at both M.S. and Ph.D. levels, presented data at various international conferences, published numerous book chapters and scientific papers in internationally recognised peer-reviewed journals, and has coauthored several patents related to novel compounds for the potential treatment of psychiatric/neurological disorders.

Biography Updated on 22 January 2013

Scholarly Contributions [Data Provided by scopus]